In particular, a study showed that the LSD1 inhibitor bomedemstatin combined with PD-1 blockade promoted a hot TME by increasing CD8+ T cell infiltration, thus significantly reducing tumor growth in a syngeneic model of SCLC [167,168] (Figure 2). Here, CD8A is linked to neoplasm.